Latent variable indirect response joint modeling of a continuous and a categorical clinical endpoint.
about
Improvement in latent variable indirect response modeling of multiple categorical clinical endpoints: application to modeling of guselkumab treatment effects in psoriatic patients.Improvement in latent variable indirect response joint modeling of a continuous and a categorical clinical endpoint in rheumatoid arthritis.Population Pharmacokinetic Modeling of Guselkumab, a Human IgG1λ Monoclonal Antibody Targeting IL-23, in Patients with Moderate to Severe Plaque Psoriasis.Modeling Composite Assessment Data Using Item Response Theory.
P2860
Latent variable indirect response joint modeling of a continuous and a categorical clinical endpoint.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Latent variable indirect respo ...... categorical clinical endpoint.
@en
Latent variable indirect respo ...... categorical clinical endpoint.
@nl
type
label
Latent variable indirect respo ...... categorical clinical endpoint.
@en
Latent variable indirect respo ...... categorical clinical endpoint.
@nl
prefLabel
Latent variable indirect respo ...... categorical clinical endpoint.
@en
Latent variable indirect respo ...... categorical clinical endpoint.
@nl
P2093
P2860
P1476
Latent variable indirect respo ...... categorical clinical endpoint.
@en
P2093
Alan M Mendelsohn
Chuanpu Hu
Honghui Zhou
Philippe O Szapary
P2860
P2888
P304
P356
10.1007/S10928-014-9366-0
P577
2014-07-20T00:00:00Z